Skip to content
knowrare
HealthSignal
Your condition community

Living with ITM2B amyloidosis

A rare inherited brain disease in adults that causes worsening memory and thinking and balance problems.

Understanding ITM2B amyloidosis

ITM2B amyloidosis is a rare neurodegenerative disease that causes progressive dementia and trouble with balance and coordination (ataxia).

It involves protein deposits (amyloid) in the brain and its blood vessels. It starts in adulthood. There are two subtypes, ABri amyloidosis and ADan amyloidosis.

Signs & symptoms

Symptoms vary from person to person. GARD lists these among the most common:

  • Dementia
  • Progressive problems with balance and coordination (ataxia)
  • Stiffness and weakness in the arms and legs (spastic tetraparesis)
  • Hearing loss
  • Clouding of the lens (cataract)
  • Amyloid in brain blood vessels

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Specialists who may be involved include autoimmune and inflammatory disease specialists, brain and nervous system specialists and genetic specialists.

  3. Ask which tests can help

    Your care team will decide which exams and tests can confirm the diagnosis.

  4. Connect with expert centers

    Amyloidosis Foundation may keep lists of experts for this condition.

Care & treatment

Care team
autoimmune and inflammatory disease specialists (rheumatologists); Brain and nervous system specialists (neurologists); Genetic specialists (geneticists)
Expert care
Expert lists: Amyloidosis Foundation
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with Amyloidosis Foundation
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
Which subtype, ABri or ADan, do I have?
Can genetic testing help my relatives understand their risk?
Which specialists and supports can help with memory and movement?

Quick facts

Symptoms usually startAdult
InheritanceAutosomal Dominant

GARD says changes in genes (also called variants) cause this condition. It is autosomal dominant, meaning one changed copy of the gene is enough to cause it.

GeneticNeurological

Also known as: familial cerebral amyloid angiopathy; itm2b-related amyloidosis; itm2b-related cerebral amyloid angiopathy

Patient organizations

Source: NIH GARD · ITM2B amyloidosisGARD ID 17741 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with ITM2B amyloidosis.

Explore the ITM2B amyloidosis blog

Explore research for ITM2B amyloidosis

Explore actively recruiting ITM2B amyloidosis studies with HealthSpark.

HealthSpark

Find actively recruiting studies for ITM2B amyloidosis with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting ITM2B amyloidosis studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for ITM2B amyloidosis

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor ITM2B amyloidosis

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your ITM2B amyloidosis experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.